Skip to main content

Primary Care Reports

RSS  

Articles

  • The Best-Seller Diets: Their Claims, Recipes, and Nutritionals

    Several excellent reviews have considered the advantages and disadvantages of popular diets, including those that feature dietary protein, but none has focused exclusively on a sample of best-seller diets, as enjoyed by the public. This article analyzes the claims of, scientific evidence for, and sustainability of 6 popular bestseller diets, along with their published recipes.
  • Pharmacology Watch: Vardenafil Will Compete for Share of ED Market

    The FDA has approved vardenafil (LevitraBayer and GlaxoSmithKline) for the treatment of erectile dysfunction in men.
  • Clinical Briefs in Primary Care Supplement

    A Strategy to Reduce Cardiovascular Disease by More Than 80 Percent; Pearly Penile Papules: Still No Reason for Uneasiness; The Epidemiology of Major Depressive Disorder; Urinary Tetrahydroaldosterone as a Screen for Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed Covers in Patients with Allergic Rhinitis
  • Infertility

    Infertility is a common condition and usually presents to the primary care physician initially. Infertility is defined as 1 year of unprotected intercourse in which a pregnancy has not been achieved. Fifteen to twenty percent of couples in the United States are infertile, and this rate has remained relatively stable since the early 1980s.
  • Clinical Briefs in Primary Care Supplement

    Insulin Plus Metformin vs Triple Oral Therapy in Type 2 Diabetes; ARB and ACE-I in Diabetic Nephropathy; Low-Glycemic Index Diets and Diabetes; Ultralow-Dose Estrogen and Bone in Older Women; Effect of Intensity of Oral Anticoagulation in Atrial Fibrillation; Patient Knowledge and Awareness of Hypertension
  • Pharmacology Watch: Generic Paxil Scheduled to Hit Market this Fall

    A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
  • Allergies and Allergy Therapy — Part I

    The objective of this monograph is to provide an overview of the scope of allergic disorders, and review the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, we will limit our discussion to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved will be reviewed, particularly the relationship between allergic rhinitis and asthma. Part I includes the current evaluation, including historical features, exposures, physical exam findings, and ancillary diagnostic options will be reviewed.
  • Pharmacology Watch: Eplerenone Cleared for CHF Patients with Sustained MI

    The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
  • Clinical Briefs in Primary Care Supplement

  • Clinical Briefs in Primary Care Supplement

    Influenza Vaccination and Reduction in Hospitalizations; Screening Men for Prostate and Colorectal Cancer; Weight Loss in CHF and Treatment with ACE-I; Impaired Fasting Glucose vs Impaired Glucose Tolerance; Risk Stratification in Long-QT Syndrome; EBCT, Motivation, Behavioral Change, and Cardiovascular Risk Profile